Icon

ILEVRO (nda203491)- (0.3%)

NEPAFENAC HARROW EYE
0.3%
Yes No
2032-Mar-31 Expired
None 2015-Oct-16
None No
ILEVROTM (nepafenac ophthalmic suspension), 0.3% is a nonsteroidal, anti-inflammatory prodrug indicated for the treatment of pain and inflammation associated with cataract surgery.
0 0 0
Total Other Developers 11
Drugs with Suitability No
0.3% ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.